Application 203858

Type
NDA
Sponsor
AEGERION

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001JUXTAPIDLOMITAPIDE MESYLATECAPSULE;ORALEQ 5MG BASEYesNo
002JUXTAPIDLOMITAPIDE MESYLATECAPSULE;ORALEQ 10MG BASEYesNo
003JUXTAPIDLOMITAPIDE MESYLATECAPSULE;ORALEQ 20MG BASEYesNo
004JUXTAPIDLOMITAPIDE MESYLATECAPSULE;ORALEQ 30MG BASEYesNo
005JUXTAPIDLOMITAPIDE MESYLATECAPSULE;ORALEQ 40MG BASEYesNo
006JUXTAPIDLOMITAPIDE MESYLATECAPSULE;ORALEQ 60MG BASEYesYes
007JUXTAPIDLOMITAPIDE MESYLATECAPSULE;ORALEQ 2MG BASEYesNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
76431-105Juxtapidlomitapide mesylateAmryt Pharmaceutcials DACNDACurrent
76431-105Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-105Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-105Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-105Juxtapidlomitapide mesylateAmryt Pharmaceuticals DACNDACurrent
76431-105Juxtapidlomitapide mesylateAmryt Pharmaceutcials DACNDACurrent
76431-110Juxtapidlomitapide mesylateAmryt Pharmaceutcials DACNDACurrent
76431-110Juxtapidlomitapide mesylateAmryt Pharmaceutcials DACNDACurrent
76431-110Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-110Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-110Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-110Juxtapidlomitapide mesylateAmryt Pharmaceuticals DACNDACurrent
76431-120Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-120Juxtapidlomitapide mesylateAmryt Pharmaceuticals DACNDACurrent
76431-120Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-120Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-120Juxtapidlomitapide mesylateAmryt Pharmaceutcials DACNDACurrent
76431-120Juxtapidlomitapide mesylateAmryt Pharmaceutcials DACNDACurrent
76431-130Juxtapidlomitapide mesylateAmryt Pharmaceutcials DACNDACurrent
76431-130Juxtapidlomitapide mesylateAmryt Pharmaceutcials DACNDACurrent
76431-130Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-130Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-130Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-130Juxtapidlomitapide mesylateAmryt Pharmaceuticals DACNDACurrent
76431-140Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-140Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-140Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-160Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-160Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent
76431-160Juxtapidlomitapide mesylateAegerion Pharmaceuticals, Inc.NDACurrent

Documents

DocumentSubmission typeDate
85174SUPPL 2026-03-02
85175SUPPL 2026-02-27
71488SUPPL2022-06-30
71350SUPPL2022-06-17
70045SUPPL2022-02-02
67626SUPPL2021-05-28
61444SUPPL2019-12-26
61419SUPPL2019-12-23
54456SUPPL2018-06-05
49241SUPPL2017-08-04
49229SUPPL2017-08-04
49164SUPPL2017-07-31
46673SUPPL2017-01-05
46672SUPPL2017-01-05
32476SUPPL2016-05-25
19501SUPPL2016-05-25
40330SUPPL2016-03-14
32475SUPPL2016-03-10
19500SUPPL2015-04-24
10258SUPPL2015-04-24
19499SUPPL2014-08-12
10257SUPPL2014-08-11
19498SUPPL2014-02-19
10256SUPPL2014-02-19
10255SUPPL2013-08-15
32474SUPPL2013-04-16
19497SUPPL2013-04-16
22936ORIG2013-02-11
19496ORIG2012-12-31
44590ORIG2012-12-28
32473ORIG2012-12-27